Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Meta-analysis
100%
Heart Failure Patients
100%
Randomized Controlled Trial
100%
Catheter Ablation
100%
Atrial Fibrillation Ablation
100%
Rate Control
60%
Left Ventricular Ejection Fraction
50%
95% Confidence Interval
50%
Atrial Fibrillation
40%
Patients with Heart Failure
30%
Antiarrhythmic Drugs
30%
Quality of Life
20%
Maximal Oxygen Uptake
20%
Persistent Atrial Fibrillation
20%
Ablation Strategy
20%
Rhythm Control
20%
Heart Atrial
20%
Heart Failure
10%
Ablation
10%
Quality of Life Improvement
10%
Success Rate
10%
Relative Risk
10%
Random Effects Model
10%
Adverse Event Rates
10%
Functional Capacity
10%
Should Be Given
10%
Major Adverse Events
10%
Risk Ratio
10%
Exclusion Criteria
10%
Jadad Score
10%
6-minute Walk Distance (6MWD)
10%
Mantel-Haenszel
10%
Drug Refractory
10%
Refractory Atrial Fibrillation
10%
Cochran's Q
10%
Background Rhythm
10%
Rate Control Strategy
10%
Minnesota Living with Heart Failure Questionnaire (MLHFQ)
10%
Minnesota Living with Heart Failure
10%
6-min Walk Test (6MWT)
10%
Medicine and Dentistry
Atrial Fibrillation
100%
Randomized Controlled Trial
100%
Meta-Analysis
100%
Congestive Heart Failure
100%
Ablation
100%
Atrial Fibrillation Ablation
66%
Heart Left Ventricle Ejection Fraction
55%
Quality of Life
33%
Antiarrhythmic Agent
33%
Rhythm
22%
Oxygen Consumption
22%
Persistent Atrial Fibrillation
22%
Adverse Event
11%
Random Effects Model
11%
Functional Status
11%
Six Minute Walk Test
11%
Nursing and Health Professions
Meta Analysis
100%
Congestive Heart Failure
100%
Atrial Fibrillation
100%
Ablation
100%
Confidence Interval
33%
Heart Left Ventricle Ejection Fraction
33%
Antiarrhythmic Agent
20%
Quality of Life
20%
Persistent Atrial Fibrillation
13%
Oxygen Consumption
13%
Walking Distance
6%
Functional Status
6%
Adverse Event
6%
Control Strategy
6%
Six Minute Walk Test
6%